Drug Type Therapeutic vaccine, mRNA vaccine |
Synonyms pp65 RNA loaded lipid particles |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Recurrent Glioblastoma | Phase 1 | United States | 02 Dec 2024 |
Phase 2 | 175 | GM-CSF+pp65-shLAMP DC (Arm 1: pp65-shLAMP DC With GM-CSF and Td) | jonbmehdlx(bwkgjvpfux) = bhidvuzbqi ulylbxtamz (kxjsrgsvwk, 759.9) View more | - | 14 Jan 2025 | ||
GM-CSF (Arm 2: pp65-flLAMP DC With GM-CSF and Td) | jonbmehdlx(bwkgjvpfux) = kgiwevjiuu ulylbxtamz (kxjsrgsvwk, 377.5) View more |